JPRN-UMIN000016807已完成未知
Pathophysiology clarification of spasmodic dysphonia by functional MRI - Analysis of spasmodic dysphonia by fMRI
Graduate School of Medicine, Kyoto University0 个研究点目标入组 22 人开始时间: 2015年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 22
研究概览
简要总结
We found overactivation in the left sensorimotor cortex and the left thalamus in SD patients, suggesting that voice perception activates different neural systems between SD patients and healthy participants. For SD patients, moreover, the magnitude of sensorimotor activation showed a significant positive correlation with symptom severity measured by voice handicap index-10, suggesting that signals from the sensorimotor cortex can be a new biomarker for assessing disease severity.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 65years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients of dysphasia, organic disease of vocal code History of botulinum toxin treatment less than 6 months before participation Patients of mental disease Patients of abuse of alchocol or medication
研究者
相似试验
尚未招募
2 期
A Phase 2 Trial of Deep Brain Stimulation for Spasmodic DysphoniaSpasmodic DysphoniaNCT04938154University of British Columbia16
已完成
不适用
Neuropathology of Spasmodic DysphoniaVoice DisordersSpasmodic DysphoniaHealthyMovement DisorderFocal DystoniaNCT00118586National Institute of Neurological Disorders and Stroke (NINDS)97
已完成
不适用
Thalamic Deep Brain Stimulation for Spasmodic Dysphonia- DEBUSSY TrialSpasmodic DysphoniaLaryngeal DystoniaDeep Brain StimulationNCT02558634University of British Columbia6
已完成
2 期
Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment ResponseSpasmodic DysphoniaVoice TremorNCT01961297Kristina Simonyan53
已完成
1 期
DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic DysphoniaAdductor Spasmodic DysphoniaVoice DisordersSpasmodic DysphoniaNCT05158166University of California, San Francisco22
